Shangfei He

554 total citations
20 papers, 410 citations indexed

About

Shangfei He is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Shangfei He has authored 20 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Cardiology and Cardiovascular Medicine and 4 papers in Molecular Biology. Recurrent topics in Shangfei He's work include Autophagy in Disease and Therapy (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Shangfei He is often cited by papers focused on Autophagy in Disease and Therapy (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Shangfei He collaborates with scholars based in China, United States and Japan. Shangfei He's co-authors include Aihua Chen, Xianbao Wang, Lu Tang, Yuanna Ling, Ying Tang, Shanshan Fu, Pingzhen Yang, Ya Zhang, Wei‐Ping Pan and Yongsheng Zhang and has published in prestigious journals such as Chemical Engineering Journal, Biochemical and Biophysical Research Communications and Cellular and Molecular Life Sciences.

In The Last Decade

Shangfei He

18 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shangfei He China 11 130 97 95 57 49 20 410
Ke Qian China 14 252 1.9× 111 1.1× 55 0.6× 25 0.4× 41 0.8× 35 607
Sandra Frotschnig Austria 6 227 1.7× 38 0.4× 64 0.7× 64 1.1× 41 0.8× 7 480
Attila Czompa Hungary 12 179 1.4× 65 0.7× 121 1.3× 39 0.7× 27 0.6× 16 466
Victoriane Peugnet France 4 149 1.1× 24 0.2× 71 0.7× 53 0.9× 40 0.8× 4 449
Irmak Ferah Okkay Türkiye 14 131 1.0× 41 0.4× 51 0.5× 30 0.5× 42 0.9× 31 455
Judith Bernal‐Ramírez Mexico 14 184 1.4× 41 0.4× 99 1.0× 17 0.3× 33 0.7× 24 466
Aymelek Gönenç Türkiye 12 239 1.8× 29 0.3× 72 0.8× 104 1.8× 44 0.9× 23 672
Sonia Sifuentes-Franco Mexico 8 153 1.2× 55 0.6× 36 0.4× 34 0.6× 51 1.0× 19 512
Qunxia Mao China 8 116 0.9× 22 0.2× 50 0.5× 67 1.2× 28 0.6× 13 351
Claudia Borșa Romania 8 107 0.8× 74 0.8× 49 0.5× 77 1.4× 56 1.1× 11 493

Countries citing papers authored by Shangfei He

Since Specialization
Citations

This map shows the geographic impact of Shangfei He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shangfei He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shangfei He more than expected).

Fields of papers citing papers by Shangfei He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shangfei He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shangfei He. The network helps show where Shangfei He may publish in the future.

Co-authorship network of co-authors of Shangfei He

This figure shows the co-authorship network connecting the top 25 collaborators of Shangfei He. A scholar is included among the top collaborators of Shangfei He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shangfei He. Shangfei He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Wang, Min, Liang Peng, Lingling Xu, et al.. (2025). MICRORNA-146B TARGETS HIF-1Α AND ATTENUATES CARDIOMYOCYTE APOPTOSIS AND FIBROSIS IN DOXORUBICIN-INDUCED HEART FAILURE. Shock. 63(4). 656–663.
5.
Zhou, Haobin, Haoyu Song, Yuanqing Li, et al.. (2024). LncRNA CARMN inhibits abdominal aortic aneurysm formation and vascular smooth muscle cell phenotypic transformation by interacting with SRF. Cellular and Molecular Life Sciences. 81(1). 175–175. 14 indexed citations
6.
Lü, Rui, et al.. (2023). Case report: Takotsubo syndrome following percutaneous coronary intervention. Journal of Cardiothoracic Surgery. 18(1). 335–335.
7.
Lin, Weidong, Huiyi Liu, Yanlin Chen, et al.. (2023). Prevalence and incidence of heart failure among community in China during a three-year follow-up. Journal of Geriatric Cardiology. 20(4). 284–292. 2 indexed citations
8.
He, Shangfei, Xudong Liu, Fangzhou Liu, et al.. (2022). Prevalence of congenital heart disease among school children in Qinghai Province. BMC Pediatrics. 22(1). 331–331. 7 indexed citations
9.
He, Shangfei, Hai Deng, Fangzhou Liu, et al.. (2021). The Evolving Epidemiology of Elderly with Degenerative Valvular Heart Disease: The Guangzhou (China) Heart Study. BioMed Research International. 2021(1). 9982569–9982569. 12 indexed citations
10.
Zheng, Murui, Shangfei He, Jun Huang, et al.. (2021). Association between physical activity and risk of obstructive sleep apnea. Sleep And Breathing. 25(4). 1925–1934. 12 indexed citations
11.
He, Shangfei, Fangzhou Liu, Hongtao Liao, et al.. (2021). Prevalence and modifiable risk factors of degenerative valvular heart disease among elderly population in southern China.. PubMed. 18(7). 523–533. 6 indexed citations
12.
Wang, Tao, Shangfei He, Yongsheng Zhang, Jiawei Wang, & Wei‐Ping Pan. (2020). Photocatalytic removal of elemental mercury on TiO2-BiOIO3 heterostructures: Mercury transformation, sulfur tolerance and SO2/SO3 conversion. Chemical Engineering Journal. 388. 124390–124390. 40 indexed citations
13.
Liu, Haiqiong, Xudong Song, Yuanna Ling, et al.. (2019). Honokiol post-treatment ameliorates myocardial ischemia/reperfusion injury by enhancing autophagic flux and reducing intracellular ROS production. Chemico-Biological Interactions. 307. 82–90. 31 indexed citations
14.
Deng, Hai, Weidong Lin, Shangfei He, et al.. (2019). Association between elevated blood glucose level and non-valvular atrial fibrillation: a report from the Guangzhou heart study. BMC Cardiovascular Disorders. 19(1). 270–270. 10 indexed citations
15.
Zeng, Qing, He He, Xianbao Wang, et al.. (2018). Electroacupuncture Preconditioning Improves Myocardial Infarction Injury via Enhancing AMPK-Dependent Autophagy in Rats. BioMed Research International. 2018. 1–9. 27 indexed citations
16.
Tang, Lu, Shangfei He, Ya Zhang, et al.. (2017). Urolithin A alleviates myocardial ischemia/reperfusion injury via PI3K/Akt pathway. Biochemical and Biophysical Research Communications. 486(3). 774–780. 89 indexed citations
17.
Zhang, Ya, Yuanna Ling, Li Yang, et al.. (2017). Liraglutide relieves myocardial damage by promoting autophagy via AMPK-mTOR signaling pathway in zucker diabetic fatty rat. Molecular and Cellular Endocrinology. 448. 98–107. 68 indexed citations
18.
He, Shangfei, Xianbao Wang, Lu Tang, et al.. (2017). Hesperetin post-treatment prevents rat cardiomyocytes from hypoxia/reoxygenation injury in vitro via activating PI3K/Akt signaling pathway. Biomedicine & Pharmacotherapy. 91. 1106–1112. 32 indexed citations
19.
He, Shangfei, Xianbao Wang, & Aihua Chen. (2017). Myocardial ischemia/reperfusion injury: the role of adaptor proteins Crk. Perfusion. 32(5). 345–349. 9 indexed citations
20.
He, Shangfei, Ya Zhang, Lu Tang, et al.. (2017). Trimetazidine Protects Cardiomyocytes Against Hypoxia/Reoxygenation Injury by Promoting AMP-activated Protein Kinase–dependent Autophagic Flux. Journal of Cardiovascular Pharmacology. 69(6). 389–397. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026